Quadrant Capital Group LLC Alkermes Plc. Transaction History

Quadrant Capital Group LLC

  • $2.65 Billion
  • Q1 2025

A detailed history of Quadrant Capital Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 19,621 shares of ALKS stock, worth $574,110. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,621
Previous 4,031 386.75%
Holding current value
$574,110
Previous $115,000 462.61%
% of portfolio
0.02%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$28.08 - $36.0 $437,767 - $561,240
15,590 Added 386.75%
19,621 $647,000
Q4 2024

Feb 12, 2025
BUY
$25.7 - $31.46 $5,782 - $7,078
225 Added 5.91%
4,031 $115,000
Q3 2024

Nov 12, 2024
BUY
$23.01 - $28.55 $15,508 - $19,242
674 Added 21.52%
3,806 $106,000
Q2 2024

Aug 12, 2024
BUY
$23.21 - $27.24 $9,933 - $11,658
428 Added 15.83%
3,132 $75,000
Q1 2024

May 15, 2024
BUY
$26.4 - $32.56 $63,808 - $78,697
2,417 Added 842.16%
2,704 $73,000
Q4 2023

Feb 08, 2024
BUY
$23.37 - $28.68 $2,804 - $3,441
120 Added 71.86%
287 $7,000
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $244 - $287
9 Added 5.7%
167 $4,000
Q2 2022

Aug 09, 2022
SELL
$26.4 - $30.54 $105 - $122
-4 Reduced 2.47%
158 $5,000
Q4 2021

Feb 01, 2022
SELL
$21.47 - $32.08 $450 - $673
-21 Reduced 11.48%
162 $4,000
Q3 2021

Nov 12, 2021
BUY
$23.37 - $32.13 $350 - $481
15 Added 8.93%
183 $6,000
Q2 2021

Aug 09, 2021
BUY
$18.78 - $25.15 $187 - $251
10 Added 6.33%
168 $4,000
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $1,492 - $2,143
97 Added 159.02%
158 $3,000
Q3 2020

Nov 13, 2020
BUY
$16.16 - $20.66 $985 - $1,260
61 New
61 $1,000
Q2 2020

Aug 13, 2020
SELL
$13.31 - $19.41 $18,900 - $27,562
-1,420 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$13.06 - $21.24 $18,545 - $30,160
1,420 New
1,420 $20,000
Q3 2019

Oct 24, 2019
SELL
$19.51 - $24.28 $19,549 - $24,328
-1,002 Closed
0 $0
Q2 2019

Jul 24, 2019
BUY
$21.47 - $37.33 $19,516 - $33,932
909 Added 977.42%
1,002 $22,000
Q1 2019

Apr 29, 2019
SELL
$28.4 - $36.49 $766 - $985
-27 Reduced 22.5%
93 $2,000
Q4 2018

Jan 17, 2019
BUY
$27.94 - $44.61 $111 - $178
4 Added 3.45%
120 $1,000
Q3 2018

Oct 29, 2018
BUY
$38.6 - $46.12 $579 - $691
15 Added 14.85%
116 $2,000
Q2 2018

Aug 09, 2018
SELL
$40.56 - $51.36 $486 - $616
-12 Reduced 10.62%
101 $2,000
Q4 2017

Jan 31, 2018
SELL
$47.69 - $55.39 $2,098 - $2,437
-44 Reduced 28.03%
113 $3,000
Q2 2017

Aug 15, 2017
BUY
N/A
157
157 $6,000

Others Institutions Holding ALKS

# of Institutions
410
Shares Held
177M
Call Options Held
229K
Put Options Held
436K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.81B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email